Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor bright

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 2996-3006

  Shankar, Malini ^a   Nixon, Jamee C ^a   Maier, Shannon ^a   Woriowan, Jennifer ^a   Farris, A Darise ^a,b   Webb, Carol F ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BRUTON TYROSINE KINASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRIGHT; TRANSCRIPTION FACTOR II; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; GLOMERULUS; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SPLEEN CELL; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 33847392377     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.5.2996     Document Type: Article

References (69)

1. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
2. Anolik, J., and I. Sanz. 2004. B cells in human and murine systemic lupus erythematosus. Curr. Opin. Rheumatol. 16: 505-512.
3. Fields, M. L., B. D. Hondowicz, G. N. Wharton, B. S. Adair, M. H. Metzgar, S. T. Alexander, A. J. Caton, and J. Erikson. 2005. The regulation and activation of lupus-associated B cells. Immunol. Rev. 204: 165-183.
4. Nemazee, D. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18: 19-51.
5. Melamed, D., and D. Nemazee. 1997. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA 94: 9267-9272.
6. Goodnow, C. C., and A. Basten. 1989. Self-tolerance in B lymphocytes. Semin. Immunol. 1: 125-135.
7. Heltemes-Harris, L., X. Liu, and T. Manser. 2004. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype. J. Immunol. 172: 823-833.
8. Norvell, A., M. L. Birkeland, J. Carman, A. L. Sillman, R. Wechsler-Reya, and J. G. Monroe. 1996. Use of isolated immature-stage B cells to understand negative selection and tolerance induction at the molecular level. Immunol. Res. 15: 191-207.
9. Su, T. T., and D. J. Rawlings. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168: 2101-2110.
10. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72: 325-335.
11. William, J., C. Euler, N. Primarolo, and M. J. Shlomchik. 2006. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol. 176: 2142-2151.
12. Metcalf, E. S., and N. R. Klinman. 1976. In vitro tolerance induction of neonatal murine B cells. J. Exp. Med. 143: 1327-1340.
13. Subramanian, S., Y. S. Yim, K. Liu, K. Tus, X. J. Zhou, and E. K. Wakeland. 2005. Epistatic suppression of systemic lupus erythematosus: fine mapping of Slesl to less than 1 mb. J. Immunol. 175: 1062-1072.
14. Chen, Y., D. Perry, S. A. Boackle, E. S. Sobel, H. Molina, B. P. Croker, and L. Morel. 2005. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus SleIc. J. Immunol. 175: 1080-1089.
15. Wakui, M., L. Morel, E. J. Butfiloski, C. Kirn, and E. S. Sobel., 2005. Genetic dissection of systemic lupus erythematosus pathogenesis: partial functional complementation between Slel and Sle3/5 demonstrates requirement for intracellular coexpression for full phenotypic expression of lupus. J. Immunol. 175: 1337-1345.
16. Webb, C. F., C. Das, S. Eaton, K. Calame, and P. W. Tucker. 1991. Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol. 11: 5197-5205.
17. Webb, C. F., C. Das, K. L. Eneff, and P. W. Tucker. 1991. Identification of a matrix-associated region 5′ of an immunoglobulin heavy chain variable region gene. Mol. Cell. Biol. 11: 5206-5211.
18. Goebel, P., A. Montalbano, N. Ayers, E. Kompfner, L. Dickinson, C. F. Webb, and A. J. Feeney. 2002. High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes. J. Immunol. 169: 2477-2487.
19. Herrscher, R. F., M. H. Kaplan, D. L. Lelsz, C. Das, R. Scheuermann, and P. W. Tucker. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9: 3067-3082.
20. Webb, C. F., C. Das, R. L. Coffman, and P. W. Tucker. 1989. Induction of immunoglobulin m mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen. J. Immunol. 143: 3934-3939.
21. Rajaiya, J., M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb. 2005. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol. Cell Biol. 25: 2073-2084.
22. Rajaiya, J., J. C. Nixon, N. Ayers, Z. P. Desgranges, A. L. Roy, and C. F. Webb. 2006. Induction of immunoglobulin heavy chain transcription through the transcription factor Bright requires TFH-I. Mol. Cell. Biol. 26: 4758-4768.
23. Webb, C. F., E. A. Smith, K. L. Medina, K. L. Buchanan, G. Smithson, and S. Dou, 1998. Expression of Bright at two distinct stages of B lymphocyte development. J. Immunol. 160: 4747-4754.
24. Nixon, J. C., J. B. Rajaiya, N. Ayers, S. Evetts, and C. F. Webb. 2004. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell. Immunol. 228: 42-53.
25. Claflin, J. L., and J. Berry. 1988. Genetics of the phosphocholine- specific antibody response to Streptococcus pneumoniae germ-line but not mutated T15 antibodies are dominantly selected. J. Immunol. 144: 4012-4019.
26. Claflin, J. L., and M. Cubberley. 1980. Clonal nature of the immune response to phosphocholine VII. Evidence throughout inbred mice for molecular similarities among antibodies bearing the T15 idiotype. J. Immunol. 125: 551-558.
27. Feeney, A. J., S. H. Clarke, and D. E. Mosier. 1988. Specific H chain junctional diversity may be required for non T15 antibodies to bind phosphorylcholine. J. Immunol. 141: 1267-1272.
28. Nixon, J. C., J. Rajaiya, and C. F. Webb. 2004. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J. Biol. Chem. 279: 52465-52472.
29. Kozak, M. 1999. Initiation of translation in prokaryotes and eukaryotes. Gene 234: 187-208.
30. Maas, A., G. M. Dingjan, F. Grosveld, and R. W. Hendriks. 1999. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region. J. Immunol. 162: 6526-6533.
31. Webb, C. F., Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith. 2000. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165: 6956-6965.
32. H families. Mol. Immunol. 34: 743-750.
33. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autotmmunity. J. Immunol. 157: 4371-4378.
34. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167: 6834-6840.
35. Rolink, A. G., J. Andersson, and F. Melchers. 2004. Molecular mechanisms guiding late stages of B-cell development. Immunol. Rev. 197: 41-50.
36. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190: 75-89.
37. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
38. Hayakawa, K., R. R. Hardy, D. R. Parks, and L. A. Herzenberg. 1983. The "LY-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
39. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3: 283-299.
40. Johnston, C. M., A. L. Wood, D. J. Bolland, and A. E. Corcoran. 2006. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J. Immunol. 176: 4221-4234.
41. Lotscher, M., H. Amstutz, C. H. Heusser, and K. Blaser. 1990. Fine specificity and heavy chain V gene usage of antibodies to the phosphorylcholine hapten. Mol. Immunol. 27: 369-378.
42. Shaw, P. X., C. S. Goodyear, M. K. Chang, J. L. Witztum, and G. J. Silverman. 2003. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J. Immunol. 170: 6151-6157.
43. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195: 181-188.
44. Yurasov, S., J. Hammersen, T. Tiller, M. Tsuiji, and H. Wardemann. 2005. B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann. NY Acad. Sci. 1062: 165-174.
45. Atencio, S., H. Amano, S. Izui, and B. L. Kotzin. 2004. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J. Immunol. 172: 4159-4166.
46. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711.
47. Samuels, J., Y. S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201: 1659-1667.
48. Quinn, W. J., III, N. Noorchashm, J. E. Crowley, A. J. Reed, H. Noorchashm, A. Naji, and M. P. Cancro. 2006. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol. 176: 7159-7164.
49. Petro, J. B., R. M. Gerstein, J. Lowe, R. S. Carter, N. Shinners, and W. N. Khan. 2002. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277: 48009-48019.
50. Brown, M., M. Stenzel-poore, and M. Rittenberg. 1985. Immunologic memory to phosphocholine VII. Lack of T15 V1 gene utilization in Xid anti-PC hybridomas. J. Immunol. 135: 3558-3563.
51. Webb, C. F. 2001. The transcription factor. Bright, and immunoglobulin heavy chain expression. Immunol. Res. 24: 149-161.
52. H1 (T15) heavy chain. Int. Immunol. 12: 873-885.
53. Kenny, J. J., L. J. Rezanka, A. Lustig, R. T. Fischer, J. Yoder, S. Marshall, and D. L. Longo. 2000. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 164: 4111-4119.
54. Hu, L., L. J. Rezanka, Q. S. Mi, A. Lustig, D. D. Taub, D. L. Longo, and J. J. Kenny. 2002. T15-idiotype-negative B cells dominate the phosphocholine binding cells in the preimmune repertoire of t15i knockin mice. J. Immunol. 168: 1273-1280.
55. Gauld, S. B., R. J. Benschop, K. T. Merrell, and J. C. Gambier. 2005. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 6: 1160-1167.
56. Kovesdi, D., K. Paszty, A. Enyedi, E. Kiss, J. Matko, K. Ludanyi, E. Rajnavolgyi, and G. Sarmay. 2004. Antigen receptor-mediated signaling pathways in transitional immature B cells. Cell Signal. 16: 881-889.
57. Carter, R. H., H. Zhao, X. Liu, M. Pelletier, W. Chatham, R. Kimberly, and T. Zhou. 2005. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum. 52: 3943-3954.
58. Khare, S. D., I. Sarosi, X. Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, G. Van, et al. 2000. Severe B cell hyperplasia and auto-immune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97: 3370-3375.
59. Rolink, A. G., and F. Melchers. 2002. BAFFIed B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14: 266-275.
60. Hibbs, M. L., K. W. Harder, J. Armes, N. Kountouri, C. Quilici, F. Casagranda, A. R. Dunn, and D. M. Tarlinton. 2002. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 196: 1593-1604.
61. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801.
62. Taylor, D. K., E. Ito, M. Thorn, K. Sundar, T. Tedder, and L. A. Spatz. 2006. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19. Mol. Immunol. 43: 1776-1790.
63. Tian, J., D. Zekzer, Y. Lu, H. Dang, and D. L. Kaufman. 2006. B cells are crucial for determinant spreading of T cell autoimmunity among β cell antigens in diabetes-prone nonobese diabetic mice. J. Immunol. 176: 2654-2661.
64. Wu, H. Y., A. Monsonego, and H. L. Weiner. 2006. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. J. Autoimmun. 26: 116-126.
65. Langnickel, D., P. Enghard, C. Klein, R. Undeutsch, B. Hocher, R. Manz, G. R. Burmester, and G. Riemekasten. 2006. Induction of pathogenic anti-dsDNA antibodies is controlled on the level of B cells in a non-lupus prone mouse strain. J. Clin. Immunol. 26: 86-95.
66. low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113: 161-171.
67. McClain, M. T., L. D. Heinlen, G. J. Dennis, J. Roebuck, J. B. Harley, and J. A. James. 2005. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11: 85-89.
68. Jackson, S. M., and J. D. Capra. 2005. IgH V-region sequence does not predict the survival fate of human germinal center B cells. J. Immunol. 174: 2805-2813.
69. Samuels, J., Y. S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Human B cell tolerance and its failure in rheumatoid arthritis. Ann. NY Acad. Sci. 1062: 116-126.